文献速递甲状腺与颈部外科

甲状腺切除术对甲状腺乳头状癌和良性甲状腺肿循环血管生成细胞因子的影响:潜在新生物标志物?

Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
PubMed 文献 · Surgery · 2020-05-30

结果显示两组术前血管生成因子均高于对照,术后血管生成素-2、成纤维细胞生长因子-2、肝细胞生长因子和肝素结合表皮生长因子均下降,但只有甲状腺乳头状癌组血小板衍生生长因子-BB和血管内皮生长因子-A术后下降。提示血管内皮生长因子-A和血小板衍生生长因子-BB可能作为甲状腺乳头状癌治疗效果的生物标志物。

要点

  • 甲状腺乳头状癌和良性甲状腺肿患者术前多种循环血管生成因子水平均高于健康对照。
  • 全甲状腺切除术后两组血管生成素-2、成纤维细胞生长因子-2、肝细胞生长因子和肝素结合表皮生长因子均下降。
  • 仅甲状腺乳头状癌组术后血小板衍生生长因子-BB和血管内皮生长因子-A下降,可能作为治疗效果的生物标志物。

核心结论

  • 血管内皮生长因子-A和血小板衍生生长因子-BB有潜力作为甲状腺乳头状癌治疗效果的生物标志物。
  • 结果值得进一步研究,可能具有预后意义。

研究设计与样本

  • 检测术前和术后2周血清中8种血管生成因子水平,采用酶联免疫吸附试验测定。

主要发现

  • 两组术前循环血管生成因子水平均高于对照(P < .0001)。
  • 术后血管生成素-2(P < .0001)、成纤维细胞生长因子-2(P < .0001)、肝细胞生长因子(P < .001)和肝素结合表皮生长因子(P < .01)水平下降。
  • 仅甲状腺乳头状癌组术后血小板衍生生长因子-BB和血管内皮生长因子-A下降(P = .001)。

临床怎么用

  • 甲状腺切除术后监测血管内皮生长因子-A和血小板衍生生长因子-BB可能有助于评估甲状腺乳头状癌的治疗效果。
  • 目前证据尚不支持常规临床应用,需进一步研究验证。

局限性

  • 单中心研究,结果需外部验证。
  • 未报告无病生存或复发等长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Circulating angiogenic factors have been associated with clinical outcomes of papillary thyroid carcinoma, although they may also be released in the context of benign multinodular goiter. We sought to investigate the effect of thyroidectomy on the activity and importance of multiple circulating angiogenic factors in papillary thyroid carcinoma and benign multinodular goiter. METHODS: Between May 2015 and December 2016, patients scheduled for total thyroidectomy for papillary thyroid carcinoma or benign multinodular goiter were offered to enroll in this study. Serum levels of angiopoietin-2, fibroblast growth factor-2, hepatocyte growth factor, platelet-derived growth factor-BB, placenta growth factor, heparin-binding epidermal growth factor, and vascular endothelial growth factor-A and -C were collected preoperatively and 2 weeks postsurgery. These levels were measured by enzyme-linked immunosorbent assay and compared with those of 35 healthy control subjects. RESULTS: Sixty patients with a median age of 52 years, 37 of whom were females, were included: 36 had papillary thyroid carcinoma, and 24 had benign multinodular goiter. In both benign multinodular goiter and papillary thyroid carcinoma, preoperative, circulating angiogenic factors levels were increased with respect to controls (P < .0001), and a decrease after total thyroidectomy was observed in the levels of angiopoietin-2 (P < .0001), fibroblast growth factor-2 (P < .0001), hepatocyte growth factor (P < .001), and heparin-binding epidermal growth factor (P < .01 each). Only patients with papillary thyroid carcinomas, however, showed decrease in the postoperative levels of platelet-derived growth factor-BB and vascular endothelial growth factor-A (P = .001 each). CONCLUSION: Results from this study raise the potential for vascular endothelial growth factor-A and platelet-derived growth factor-BB to be used as biomarkers of the effectiveness of treatment of papillary thyroid carcinoma. These results warrant further investigation and may have potential prognostic implications.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Ria R, Prete F, Melaccio A, et al. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? Surgery. 2020. PMID: 32482341. doi:10.1016/j.surg.2020.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。